Dendrimers for Imaging

Dendrimers: Towards Catalytic, Material and Biomedical Uses

Volumn , Issue , 2011, Pages 393-412

  Turrin, Cédric Olivier ^a   Caminade, Anne Marie ^a  

^a LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

Applications in biology medicine dendrimers for imaging, tissue staining to antigen visualization by light microscopy; Dendrimer use, as chelating agents for MRI contrast agents, group of Wiener with gadolinium based dendrimeric complexes; Dendrimers for optical imaging luminescent emitter targeted to organ; Dendrimers, and advantages for designing contrast agents; Enhanced permeability and retention effect (EPR); Molecular imaging with dendrimers; Multimodal dendrimeric systems, and MRI contrast agents fluorescent tracers, for optical imaging in future applications; Nano objects, candidates an adequate intrinsic properties; PARACEST dendrimer based contrast agents proton density modification; PEG crosslinked multifunctional imaging dendrimers

Indexed keywords

EID: 84861836089     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119976530.ch16     Document Type: Chapter

References (96)

1. P. Debbage and W. Jaschke(2008)Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochem. Cell Biol., 130, 845-875.
2. N. Matsuura and J. A. Rowlands(2008)Towards new functional nanostructures for medical imaging. Med. Phys., 35, 4474-4487.
3. E. C. Wiener, M. W. Brechbiel, H. Brothers, R. L. Magin, O. A. Gansow, D. A. Tomalia, and P. C. Lauterbur(1994)Dendrimer-based metal-chelates. A new class of MRI contrast agents. Magn. Reson. Med., 31, 1-8.
4. A. J. L. Villaraza, A. Bumb, and M. W. Brechbiel(2010)Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem. Rev., 110, 2921-2959.
5. C. Khemtong, C. W. Kessinger, and J. M. Gao(2009)Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem. Commun., 3497-3510.
6. A. Louie(2010)Multimodality imaging probes: design and challenges. Chem. Rev., 110, 3146-3195.
7. M. Longmire, P. L. Choyke, and H. Kobayashi(2008)Dendrimer-based contrast agents for molecular imaging. Curr. Top. Med. Chem., 8, 1180-1186.
8. P. C. Lauterbur(1973)Image formation by induced local interactions: examples of employing nuclear magnetic resonance. Nature, 242, 190-191.
9. S. D. Swanson and C. R. Williams(2008)MRI using targeted dendrimer contrast agents, in Dendrimer-Based Nanomedicine (eds I. J. Majoros and J. R. Baker), Pan Stanford Publishing Pte. Ltd, Singapore.
10. L. M. De Leon-Rodriguez, A. J. M. Lubag, C. R. Malloy, G. V. Martinez, R. J. Gillies, and A. D. Sherry(2009)Responsive MRI agents for sensing metabolism in vivo. Acc. Chem. Res., 42, 948-957.
11. H. Kobayashi and M. W. Brechbiel(2005)Nano-sized MRI contrast agent with dendrimer cores, Adv. Drug Deliv. Rev., 57, 2271-2286.
12. O. M. Koo, I. Rubinstein, and H. Onyuksel(2005)Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine, 1, 193-212.
13. Y. Matsumura and H. Maeda(1986)A new concept for macromolecular of tumotropis accumulation of proteins and the antitumor agent SMANCS. Cancer Res., 46, 6387-6392.
14. H. Maeda(1992)The tumor blood vessel as an ideal target for macromolecular anticancer agents. J. Control. Rel., 19, 315-324.
15. H. Maeda, T. Sawa, and T. Konno(2001)Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Controlled Release, 74, 47-61.
16. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori(2000)Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release, 65, 271-284.
17. E. C. Wiener, S. Konda, A. Shadron, M. Brechbiel, and O. Gansow(1997)Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest. Radiol., 32, 748-754.
18. R. Jain, P. Dandekar. and V. Patravale(2009)Diagnostic nanocarriers for sentinel lymph node imaging. J. Controlled Release, 138, 90-102.
19. V. V. Mody, M. I. Nounou, and M. Bikram(2009)Novel nanomedicine-based MRI contrast agents for gynecological malignancies. Adv. Drug Delivery Rev., 61, 795-807.
20. T. Barrett, H. Kobayashi, M. Brechbiel, and P. L. Choyke(2006)Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur. J. Radiol., 60, 353-366.
21. S. Langereis, A. Dirksen, T. M. Hackeng, M. H. P. van Genderen, and E. W. Meijer(2007)Dendrimers and magnetic resonance imaging. New J. Chem., 31, 1152-1160.
22. J. H. Kim, K. Park, H. Y. Nam, S. Lee, K. Kim, and I. C. Kwon(2007)Polymers for bioimaging. Prog. Polym. Sci., 32, 1031-1053.
23. B. Helms and E. W. Meijer(2006)Dendrimers at work. Science, 313, 929-930.
24. H. Kobayashi and M. W. Brechbiel(2005)Nano-sized MRI contrast agents with dendrimer cores Adv. Drug Delivery Rev., 57, 2271-2286.
25. V. J. Venditto, C. A. S. Regino, and M. W. Brechbiel(2005)PAMAM dendrimer based macromolecules as improved contrast agents. Molec. Pharm., 2, 302-311.
26. M. D. Ogan, U. Schmiedl, M. E. Moseley, W. Grodd, H. Paajanen, and R. C. Brasch(1987)Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest. Radiol., 22, 665-671.
27. P. Loubeyre, E. Canet, S. Zhao, S. Benderbous, M. Amiel, and D. Revel(1996)Carboxymethyldextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits. Invest. Radiol., 31, 288-293.
28. G. Schuhmann-Giampieri, H. Schmitt-Willich, T. Frenzel, W. R. Press, and H. J. Weinmann(1991)In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest. Radiol., 26, 969-974.
29. E. C. Wiener, F. P. Auteri, J. W. Chen, M. W. Brechbiel, O. A. Gansow, D. S. Schneider, R. L. Belford, R. B. Clarkson, and P. C. Lauterbur(1996)Molecular-dynamics of ion-chelate complexes attached to dendrimers. J. Am. Chem. Soc., 118, 7774-7782.
30. E. C. Wiener, M. W. Brechbiel, H. Brothers, R. L. Magin, O. A. Gansow, D. A. Tomalia, and P. C. Lauterbur(1994)Dendrimer-based metal-chelates-a new class of magnetic-resonance-imaging contrast agents. Magn. Reson. Med., 31, 1-8.
31. E. C. Wiener, S. Konda, A. Shadron, M. Brechbiel, and O. Gansow(1997)Targeting dendrimer-chelates to tumors and tumor-cells expressing the high-affinity folate receptor. Invest. Radiol., 32, 748-754.
32. H. Xu, C. A. S. Regino, Y. Koyama, Y. Hama, A. J. Gunn, M. Bernardo, H. Kobayashi, P. L. Choyke, and M. W. Brechbiel(2007)Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjugate Chem., 18, 1474-1482.
33. D. G. Mullen, A. M. Desai, J. N. Waddell, X. M. Cheng, C. V. Kelly, D. Q. McNerny, I. J. Majoros, J. R. Baker, L. M. Sander, B. G. Orr, and M. M. B. Holl(2008)The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles. Bioconjugate Chem., 19, 1748-1752.
34. Y. Koyama, V. S. Talanov, M. Bernardo, Y. Hama, C. A. S. Regino, M. W. Brechbiel, P. L. Choyke, and H. Kobayashi(2007)A dendrimer-based nanosized contrast agent, dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J. Mag. Res. Imaging, 25, 866-871.
35. Y. Hama, M. Bernardo, C. A. S. Regino, Y. Koyama, M. W. Brechbiel, M. C. Krishna, P. L. Choyke, and H. Kobayashi(2007)MR lymphangiography using dendrimer-based contrast agents: a comparison at 1.5 T and 3.0 T. Magn. Reson. Med., 57, 431-436.
36. H. Xu, C. A. S. Regino, M. Bernardo, Y. Koyama, H. Kobayashi, P. L. Choyke, and M. W. Brechbiel(2007)Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriamine pentaacetic acid ligands and nonaqueous conjugation chemistry. J. Med. Chem., 50, 3185-3193.
37. M. Poláš ek, P. Hermann, J. A. Peters, C. F. G. C. Geraldes, and I. Lukes(2009)PAMAM dendrimers conjugated with an uncharged gadolinium(III) chelate with a fast water exchange: the influence of chelate charge on rotational dynamics. Bioconjugate Chem., 20, 2142-2153.
38. K. Nwe, H. Xu, C. A. S. Regino, M. Bernardo, L. Ileva, L. Riffle, K. J. Wong, and M. W. Brechbiel(2009)A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives. Bioconjugate Chem., 20, 1412-1418.
39. Z. Cheng, D. L. J. Thorek, and A. Tsourkas(2010)Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent. Angew. Chem. Int. Ed., 49, 346-350.
40. R. Z. Xu, Y. L. Wang, X. L. Wang, E. K. Jeong, D. L. Parker, and Z. R. Lu(2007)In vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent. Expl Biol. Med., 232, 1081-1089.
41. N. Malik, R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J. W. Weener, E. W. Meijer, W. Paulus, and R. Duncan(2000)Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled polyamidoamine dendrimers in vivo. J. Controlled Release, 65, 133-148.
42. D. M. Domanski, B. Klajnert, and M. Bryszewska(2004)Influence of PAMAM dendrimers on human red blood cells. Bioelectrochemistry, 63, 189-191.
43. S. D. Swanson, J. F. Kukowska-Latallo, A. K. Patri, C. Y. Chen, S. Ge, Z. Y. Cao, A. Kotlyar, A. T. East, and J. R. Baker(2008)Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int. J. Nanomed., 3, 201-210.
44. H. Sarin, A. S. Kanevsky, H. T. Wu, A. A. Sousa, C. M. Wilson, M. A. Aronova, G. L. Griffiths, R. D. Leapman, and H. Q. Vo(2009)Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors. J. Trans. Med., 7.
45. M. A. Quadir, M. R. Radowski, F. Kratz, K. Licha, P. Hauff, and R. Haag(2008)Dendritic multishell architectures for drug and dye transport. J. Controlled Release, 132, 289-294.
46. Z. Jaszberenyi, L. Moriggi, P. Schmidt, C. Weidensteiner, R. Kneuer, A. E. Merbach, L. Helm, and E. Toth(2007)Physicochemical and MRI characterization of Gd3 +-loaded polyamidoamine and hyperbranched dendrimers. J. Biol. Inorg. Chem., 12, 406-420.
47. Y. J. Fu, H. J. Raatschen, D. E. Nitecki, M. F. Wendland, V. Novikov, L. S. Fournier, C. Cyran, V. Rogut, D. M. Shames, and R. C. Brasch(2007)Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations. Biomacromolecules, 8, 1519-1529.
48. S. Langereis, Q. G. de Lussanet, M. H. P. van Genderen, E. W. Meijer, R. G. H. Beets-Tan, A. W. Griffioen, J. M. A. van Engelshoven, and W. H. Backes(2006)Evaluation of Gd(III) DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR in Biomedicine, 19, 133-141.
49. C. S. Winalski, S. Shortkroff, E. Schneider, H. Yoshioka, R. V. Mulkern, and G. M. Rosen(2008)Targeted dendrimer-based contrast agents for articular cartilage assessment by MR imaging. Osteoarthritis and Cartilage, 16, 815-822.
50. C. S. Winalski, S. Shortkroff, E. Schneider, R. V. Mulkern, A. Chatha, and G. M. Rosen. Effect of molecular properties of dendrimer-linked nitroxide MR contrast agents on cartilage enhancement. Radiology, 225, 329-329.
51. C. S. Winalski, S. Shortkroff, R. V. Mulkern, E. Schneider, and G. M. Rosen(2002)Magnetic resonance relaxivity of dendrimer-linked nitroxides. Magn. Reson. Med., 48, 965-972.
52. A. Bertin, A. I. Michou-Gallani,, J. Steibel, J. L. Gallani, and D. Felder-Flesch(2010)Synthesis and characterization of a highly stable dendritic catechol-tripod bearing technetium-99m. New J. Chem., 34, 267-275.
53. K. M. Ward, A. H. Aletras, and R. S. Balaban(2000)A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson., 143, 79-87.
54. K. M. Ward and R. S. Balaban(2000)Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn. Reson. Med., 44, 799-802.
55. L. E. Gerweck and K. Seetharaman(1996)Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res., 56, 1194-1198.
56. S. R. Zhang, M. Merritt, D. E. Woessner, R. E. Lenkinski, and A. D. Sherry(2003)PARACEST agents: modulating MRI contrast via water proton exchange. Acc. Chem. Res., 36, 783-790.
57. M. M. Ali, M. Woods, P. Caravan, A. C. L. Opina, M. Spiller, J. C. Fettinger, and A. D. Sherry(2008)Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. Chem.-Eur. J., 14, 7250-7258.
58. J. A. Pikkemaat, R. T. Wegh, R. Lamerichs, R. A. van de Molengraaf, S. Langereis, D. Burdinski, A. Y. F. Raymond, H. M. Janssen, B. F. M. de Waal, N. P. Willard, E. W. Meijer, and H. Grull(2007)Dendritic PARACEST contrast agents for magnetic resonance imaging. Contrast Media Mol. Imaging, 2, 229-239.
59. M. M. Ali, B. Yoo, and M. D. Pagel(2009)Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Molec. Pharm., 6, 1409-1416.
60. S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. V. Elst, and R. N. Muller(2008)Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev., 108, 2064-2110.
61. X. Y. Shi, S. H. Wang, S. D. Swanson, S. Ge, Z. Y. Cao, M. E. Van Antwerp, K. J. Landmark, and J. R. Baker(2008)Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in-vivo magnetic resonance imaging of tumors. Adv. Mater., 20, 1671-1678.
62. K. J. Landmark, S. DiMaggio, J. Ward, C. V. Kelly, S. Vogt, S. Hong, A. Kotlyar, A. Myc, T. P. Thomas, J. E. Penner-Hahn, J. R. Baker, M. M. B. Holl, and B. G. Orr(2008)Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic acid-conjugated dendrimers. ACS Nano, 2, 773-783.
63. S. H. Wang, X. Y. Shi, M. Van Antwerp, Z. Y. Cao, S. D. Swanson, X. D. Bi, and J. R. Baker(2007)Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells. Adv. Funct. Mater., 17, 3043-3050.
64. A. L. Martin, L. M. Bernas, B. K. Rutt, P. J. Foster, and E. R. Gillies(2008)Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. Bioconjugate Chem., 19, 2375-2384.
65. M. S. Albert, G. D. Cates, B. Driehuys, W. Happer, B. Saam, C. S. Springer, and A. Wishnia(1994)Biological magnetic-resonance-imaging using laser polarized Xe-129. Nature, 370, 199-201.
66. J. L. Mynar, T. J. Lowery, D. E. Wemmer, A. Pines, and J. M. J. Fréchet(2006)Xenon biosensor amplification via dendrimer-cage supramolecular constructs. J. Am. Chem. Soc., 128, 6334-6335.
67. Z. X. Jiang, X. Liu, E. K. Jeong, and Y. B. Yu(2009)Symmetry-guided design and fluorous synthesis of a stable and rapidly excreted imaging tracer for F-19 MRI. Angew. Chem. Int. Ed., 48, 4755-4758.
68. J. M. Criscione, B. L. Le, E. Stern, M. Brennan, C. Rahner, X. Papademetris, and T. M. Fahmy(2009)Self-assembly of pH-responsive fluorinated dendrimer-based particulates for drug delivery and noninvasive imaging. Biomaterials, 30, 3946-3955.
69. A. M. Caminade, A. Hameau, and J. P. Majoral(2009)Multicharged and/or water-soluble fluorescent dendrimers: properties and uses. Chem. Eur. J., 15, 9270-9285.
70. M. El-Sayed, M. F. Kiani, M. D. Naimark, A. H. Hikal, and H. Ghandehari(2001)Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium. Pharm. Res., 18, 23-28.
71. L. E. Samuelson, M. J. Dukes, C. R. Hunt, J. D. Casey, and D. J. Bornhop(2009)TSPO targeted dendrimer imaging agent: synthesis, characterization, and cellular internalization. Bioconjugate Chem., 20, 2082-2089.
72. M. Berna, D. Dalzoppo, G. Pasut, M. Manunta, L. Izzo, A. T. Jones, R. Duncan, and F. M. Veronese(2006)Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: synthesis, characterization and cellular uptake. Biomacromolecules, 7, 146-153.
73. A. K. Galande, S. A. Hilderbrand, R. Weissleder, and C. H. Tung(2006)Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core. J. Med. Chem., 49, 4715-4720.
74. A. Almutairi, W. J. Akers, M. Y. Berezin, S. Achilefu, and J. M. J. Fréchet(2008)Monitoring the biodegradation of dendritic near-infrared nanoprobes by in vivo fluorescence imaging. Molec. Pharm., 5, 1103-1110.
75. S. Fuchs, A. Pla-Quintana, S. Mazeres, A. M. Caminade, and J. P. Majoral (2008) Cationic and fluorescent "Janus " dendrimers. O rg. Lett., 10, 4751-4754.
76. T. R. Krishna, M. Parent, M. H. V. Werts, L. Moreaux, S. Gmouh, S. Charpak, A. M. Caminade, J. P. Majoral, and M. Blanchard-Desce(2006)Water-soluble dendrimeric two-photon tracers for in vivo imaging. Angew. Chem. Int. Ed., 45, 4645-4648.
77. O. Mongin, T. R. Krishna, M. H. V. Werts, A. M. Caminade, J. P. Majoral, and M. Blanchard-Desce(2006)A modular approach to two-photon absorbing organic nanodots: brilliant dendrimers as an alternative to semiconductor quantum dots? Chem. Commun., 915-917.
78. F. Terenziani, V. Parthasarathy, A. Pla-Quintana, T. Maishal, A. M. Caminade, J. P. Majoral, and M. Blanchard-Desce(2009)Cooperative two-photon absorption enhancement by through-space interactions in multichromophoric compounds. Angew. Chem. Int. Ed., 48, 8691-8694.
79. A. Y. Lebedev, A. V. Cheprakov, S. Sakadzic, D. A. Boas, D. F. Wilson, and S. A. Vinogradov(2009)Dendritic phosphorescent probes for oxygen imaging in biological systems. ACS App. Mater. Interf., 1, 1292-1304.
80. D. F. Wilson, W. M. F. Lee, S. Makonnen, O. Finikova, S. Apreleva, and S. A. Vinogradov(2006)Oxygen pressures in the interstitial space and their relationship to those in the blood plasma in resting skeletal muscle. J. Appl. Physiol., 101, 1648-1656.
81. I. Dunphy, S. A. Vinogradov, and D. F. Wilson(2002)Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence. Anal. Biochem., 310, 191-198.
82. R. P. Brinas, T. Troxler, R. M. Hochstrasser, and S. A. Vinogradov(2005)Phosphorescent oxygen sensor with dendritic protection and two-photon absorbing antenna. J. Am. Chem. Soc., 127, 11851-11862.
83. O. S. Finikova, A. Y. Lebedev, A. Aprelev, T. Troxler, F. Gao, C. Garnacho, S. Muro, R. M. Hochstrasser, and S. A. Vinogradov(2008)Oxygen microscopy by two-photon-excited phosphorescence. ChemPhysChem, 9, 1673-1679.
84. A. T. Yordanov, N. Mollov, A. L. Lodder, E. Woller, M. Cloninger, S. Walbridge, D. Milenic, and M. W. Brechbiel(2005)A water-soluble triiodo amino acid and its dendrimer conjugate for computerized tomography (CT) imaging. J. Serb. Chem. Soc., 70, 163-170.
85. A. T. Yordanov, A. L. Lodder, E. K. Woller, M. J. Cloninger, N. Patronas, D. Milenic, and M. W. Brechbiel(2002)Novel iodinated dendritic nanoparticles for computed tomography (CT) imaging. Nano Lett., 2, 595-599.
86. Y. J. Fu, D. E. Nitecki, D. Maltby, G. H. Simon, K. Berejnoi, H. J. Raatschen, B. M. Yeh, D. M. Shames, and R. C. Brasch(2006)Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization. Bioconjugate Chem., 17, 1043-1056.
87. R. Guo, H. Wang, C. Peng, M. W. Shen, M. J. Pan, X. Y. Cao, G. X. Zhang, and X. Y. Shi(2010)X-ray attenuation property of dendrimer-entrapped gold nanoparticles. J. Phys. Chem. C, 114, 50-56.
88. N. Sato, H. Kobayashi, T. Saga, Y. Nakamoto, T. Ishimori, K. Togashi, Y. Fujibayashi, J. Konishi, and M. W. Brechbiel(2001)Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clinical Cancer Res., 7, 3606-3612.
89. H. Kobayashi, C. Wu, M. K. Kim, C. H. Paik, T. A. Waldmann, J. A. Carrasquillo, and M. W. Brechbiel(1998)Evaluation of the biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA alone or conjugated with a monoclonal antibody. J. Nuclear Med., 39, 232-233.
90. A. Almutairi, R. Rossin, M. Shokeen, A. Hagooly, A. Ananth, B. Capoccia, S. Guillaudeu, D. Abendschein, C. J. Anderson, M. J. Welch, and J. M. J. Fréchet(2009)Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc. Natl Acad. Sci. USA, 106, 685-690.
91. X. J. Chen, S. P. Dou, G. Z. Liu, X. R. Liu, Y. Wane, L. Chen, M. Rusckowski, and D. J. Hnatowich(2008)Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting. Bioconjugate Chem., 19, 1518-1525.
92. M. C. Parrott, S. R. Benhabbour, C. Saab, J. A. Lemon, S. Parker, J. F. Valliant, and A. Adronov(2009)Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers. J. Am. Chem. Soc., 131, 2906-2916.
93. V. S. Talanov, C. A. S. Regino, H. Kobayashi, M. Bernardo, P. L. Choyke, and M. W. Brechbiel(2006)Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett., 6, 1459-1463.
94. E. S. Olson, T. Jiang, T. A. Aguilera, Q. T. Nguyen, L. G. Ellies, M. Scadeng, and R. Y. Tsien(2010)Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc. Natl Acad. Sci. USA, 107, 4311-4316.
95. Q. T. Nguyen, E. S. Olson, T. A. Aguilera, T. Jiang, M. Scadeng, L. G. Ellies, and R. Y. Tsien(2010)Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc. Natl Acad. Sci. USA, 107, 4317-4322.
96. C. A. S. Regino, S. Walbridge, M. Bernardo, K. J. Wong, D. Johnson, R. Lonser, E. H. Oldfield, P. L. Choyke, and M. W. Brechbiel(2008)A dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agents. Contrast Media Molec. Imaging, 3, 2-8.